Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Sociodemographic and Psychosocial Factors Predictive of Occurrence of MDD
2 Then and Now: Advancing Our Knowledge of MDD Comorbidities
3 Vortioxetine may reduce MDD-related cognitive impairment
4 Higher Levels of Inflammatory Markers in Patients With MDD and Suicide Risk
5 Psychosocial Factors Linked to the Development of MDD in Adults With Type 2 Diabetes
6 Spravato Approved for MDD With Acute Suicidal Ideation or Behavior
7 Potential Impact of COVID-19 Pandemic on Global Major Depressive Disorder (MDD) Market Report PDF 2020 Key Companies Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Eli Lily
8 Acadia moment of Clarity ends MDD push with Nuplazid, DRP under FDA review
9 University TMS Clinic Now Offering FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
10 Early life stress is associated with youth-onset depression for some types of stress but not others
11 Acadia pulls plug on pimavanserin for adjunctive MDD
12 Mitigating Lack of Response to Antidepressant Therapy in Major Depressive Disorder: A Game On! Challenge
13 Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
14 TMS offers similar benefit for MDD patients with and without comorbid PTSD
15 Major Depressive Disorder May Increase Risk of Dementia
16 Laparoscopic Retractors Market 2020 – Aesculap, ANSABERE SURGICAL, Locamed, Maxer Endoscopy, MDD – Medical Device, Mediflex Surgical, NovaProbe, VECTEC
17 Escitalopram combined with aripiprazole improves interest-activity reduction in MDD
18 Researchers find replicable neuroimaging features for MDD
19 Patients With MDD Have Reduced Thickness, Surface Area of Stress-Sensitive Brain Structures
20 Suicidal Ideation May Moderate Frontal Alpha Asymmetry in MDD
21 Differing Patient and Provider Perspectives May Hinder Treatment Strategies for MDD
22 Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations
23 Emotional Reactivity, Explicit Emotional Memory Biases Not Present in MDD During Euthymia
24 Dr. Vladimir Maletic on Diet and Nutrition in Patients With MDD During the Pandemic
25 Positive, Negative Valence Systems Reflect Distinct Clinical Symptoms in MDD
26 Clinical challenges in MDD patients with comorbid disorders
27 Global Major Depressive Disorder (MDD) Market Insights, 2017-2028
28 Novel Antagonist Shows Potential for MDD in Phase 2 Study
29 Integrating Psychotherapy and Psychopharmacology in the Treatment of Major Depressive Disorder
30 Sage's MDD Treatment Fails to Distinguish Itself from Placebo in Late-Stage Trial
31 Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans
32 MDD, noncombat trauma associated with suicide ideation among deployed soldiers
33 Depression Worse After Treatment in Few With MDD
34 Pimavanserin Effective Against MDD in Antidepressant Nonresponders
35 Factors Correlated With Suicidal Ideation in Major Depressive Disorder
36 IL-6 Receptor Serum Levels Can Act as a Biomarker for Treatment Resistant MDD
37 Brain measurements at age 7 can predict future ADHD, MDD risk
38 Prefrontal Cortical Activation During Working Memory Task: Distinguishing BD vs MDD
39 Symptoms of MDD May Actually Indicate Another Psychiatric Disorder
40 Major Depressive Disorder May Be a Risk Factor for Type 2 Diabetes and Coronary Artery Disease
41 Patients with MDD and suicide ideation/attempt experience significant health care costs
42 Seltorexant shows antidepressant effect in MDD
43 Psilocybin Receives Breakthrough Therapy Designation for MDD
44 Major Depressive Disorder and Improving Cognitive Functioning
45 ATR Index and Early Symptom Change Predicts Therapy-Related MDD Remission
46 Experiential avoidance a predictor for MDD, GAD in older adolescents
47 Yoga Improves Symptoms in Study Participants With MDD
48 Despite Antidepressants, Suicidal Ideation Affects 1 in 5 People With MDD
49 Moods During Depressive Episodes Differ in Bipolar and Major Depressive Disorders
50 Can Vortioxetine Ameliorate SSRI-Induced Sexual Dysfunction in Well-Treated MDD?
51 Anti-Inflammatory Treatments for MDD: Update and Expert Interview
52 Solace Behavioral Health Clinic Hosts Grand Opening to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
53 Augmentation Strategies for Depression
54 Empower Psychiatry & Sleep LLC Now Offers New Treatment for Major Depressive Disorder (MDD)
55 High Levels of Inflammation and Blood Glucose May Contribute to Anhedonia in MDD
56 Previous Antidepressant Use May Predict Remission With Venlafaxine in MDD
57 ACADIA to Merge Two Phase III Studies on Nuplazid for MDD
58 New MRI scans reveal brain features of depression
59 Psychiatry Online
60 Antidepressant Effect Seen for Anti-Inflammatories in MDD
61 Escitalopram-Memantine Combination Improves Cognitive Outcomes in Older Adults With MDD
62 West Yavapai Guidance Clinic Hosts Open House to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
63 Subthreshold Depression in Older Adults: Overview and Expert Interview
64 Ultradian Sleep Cycles Correlate With REM Alterations in Major Depression
65 Psilocybin for major depression granted Breakthrough Therapy by FDA
66 Changes in Appetite and Inflammation in Major Depressive Disorder
67 Potential Biomarker for Early Detection of Bipolar Disorder in Women With MDD
68 Long-Term Lithium Use Effective in Older Adults With MDD, Bipolar Disorder
69 Novel Dextromethorphan/Bupropion Formulation Provides Significant Benefits in MDD Trial
70 Regulatory expansion submitted for SPRAVATO® (esketamine)
71 Should Combined CBT, Pharmacotherapy Be Reconsidered in MDD?
72 Borderline Personality Disorder With Depression Raises Risk of Suicide Attempts in Mood Disorder Patients
73 ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder
74 Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder
75 Gut Microbiota Can Drive Neuroinflammation in Major Depressive Disorder
76 Praxis makes perfect? Bid to sharpen MDD drug targeting has banked $100M so far
77 Recognizing the Signs of Major Depressive Disorder (MDD)
78 Underlying Bipolar Diathesis May Contribute to Treatment Resistance in MDD
79 Psychological Treatments Linked to Improved Sleep in Youth With Major Depressive Disorder
80 Relapse More Likely With Antipsychotic Switch in Schizophrenia, Bipolar Disorder, or MDD
81 Sage Therapeutics Announces Development Plan for Zuranolone (SAGE-217) Following Breakthrough Therapy Guidance Meeting with the US Food & Drug Administration
82 Hospitalization for MDD Costly, Associated With High Readmission Rates
83 FDA grants Breakthrough Therapy Designation to Usona Institute's psilocybin program for major depressive disorder
84 Economic Burden Among Patients With Major Depressive Disorder: An Analysis of Healthcare Resource Use, Work Productivity, and Direct and Indirect Costs by Depression Severity
85 PAI-1 Deficiency Produces Antidepressant-Resistant Depressive Phenotype
86 The Remedy Is Now Offering Deep Transcranial Magnetic Stimulation (Deep TMS) Therapy to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
87 SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder
88 Ketamine Changes Course of Major Depressive Disorder Treatment
89 MDD: Closing in on the Right Drug at the Right Dose
90 Esketamine Promising in Patients With MDD Who Have Active Suicidal Ideation With Intent
91 FDA Grants Psilocybin Second Breakthrough Therapy Designation
92 In pivot, Sage turns focus to treatment-resistant depression
93 West Yavapai Guidance Clinic Hosts Open House to Introduce MDD and OCD Treatment
94 What is Major Depressive Disorder?
95 Severe Subclinical Hypothyroidism and Occurrence in Major Depressive Disorder
96 What's New in the Treatment of MDD?
97 Amid COVID-19, Dr. Rakesh Jain Shares Learnings From 33 Years of Treating MDD
98 Antidepressant Medications Show Little Clinical Benefit for Major Depressive Disorder
99 Treatment Recommendations for Major Depressive Disorder in Medical Illness
100 Suicidal Ideation Linked to Major Depressive Disorder Despite Antidepressant Therapy